The Myeloma Crowd™ Launches HealthTree® Aimed at Accelerating a Cure for Multiple Myeloma

Thursday, October 25, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

Online Platform to Improve Myeloma Patient Outcomes, Provide Researchers with Aggregate Data Never Before Available

SALT LAKE CITY, Oct. 25, 2018 /PRNewswire/ -- The Myeloma Crowd™, a division of the CrowdCare Foundation, today announced

the launch of HealthTree®, a new online tool to help Multiple Myeloma patients find their best myeloma treatments and accelerate research toward a cure.

HealthTree is the first resource of its kind where patients track their myeloma lab values across all treatments, see personally relevant treatment options they could consider, view collective reports of anonymized data, find personally relevant clinical trials and contribute de-identified data to be aggregated for review by myeloma researchers and the patient community. is led by Jenny Ahlstrom, a myeloma patient and former systems engineer for IBM, who built the tool that would have helped her when she was diagnosed. Along with her husband Paul, an investor and entrepreneur, the Ahlstrom's approached Jenny's myeloma like they would a startup company.

"The healthcare industry still acts as if the internet doesn't exist with every patient having to reinvent the wheel to learn about their disease," said Jenny Ahlstrom. "HealthTree gives the 80 percent of patients not seeing a myeloma specialist access to information from the experts that they can share with their doctor. Patients could be living years longer with today's wide range of therapies if they received the right treatment at the right time."

Using machine learning, the same technology that allows Amazon and Netflix to predict what consumers will want to buy and watch, it is possible to identify patterns that could inform treatment decisions, improve patient outcomes and advance a cure for myeloma.

Once the needs in myeloma are fully met, there are plans to expand HealthTree to other types of cancer and terminal diseases in the future.

The Ahlstroms have just completed a 50-city tour during the beta test for To date, there are already almost a thousand patients are now using the tool that will enable new hypotheses around a cure by sharing their myeloma data and experiences. 

HealthTree is free for myeloma patients. More information is available by visiting this link.

About Myeloma Crowd/CrowdCare Foundation

The Myeloma Crowd is a division of the CrowdCare Foundation, a patient-driven 501(c)3 non-profit organization. The Myeloma Crowd provides patient education, advocacy and research funding for multiple myeloma. Jennifer Ahlstrom founded the CrowdCare Foundation, Myeloma Crowd and also hosts online radio interviews with top myeloma specialists worldwide to educate patients and promote clinical trial participation.


Cision View original content:

SOURCE Myeloma Crowd: CrowdCare Foundation

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store